PACS
PACS Group, Inc.NYSEHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$5.56B
P/E Ratio
29.00
EPS
$1.22
Beta
—
52W High
$43.08
52W Low
$7.50
50-Day MA
$35.74
200-Day MA
$22.99
Dividend Yield
—
Profit Margin
3.62%
Forward P/E
14.88
PEG Ratio
0.99
About PACS Group, Inc.
PACS Group, Inc. is a leading technology solutions provider focused on enhancing operational efficiency and productivity across a wide array of industries. The company excels in developing innovative software and hardware systems that optimize workflows and enhance data management capabilities. With a strong commitment to research and development, PACS Group is well-positioned to capitalize on emerging technological trends, reinforcing its status as a key player in the digital transformation landscape. Its strategic partnerships and extensive market presence further strengthen its competitive advantage, presenting a compelling investment opportunity for institutional investors seeking growth in the evolving technology sector.
Fundamentals
| Revenue (TTM) | $5.29B |
| Gross Profit (TTM) | $818.95M |
| EBITDA | $365.26M |
| Operating Margin | 6.97% |
| Return on Equity | 23.00% |
| Return on Assets | 3.57% |
| Revenue/Share (TTM) | $33.86 |
| Book Value | $6.04 |
| Price-to-Book | 5.34 |
| Price-to-Sales (TTM) | 1.05 |
| EV/Revenue | 1.574 |
| EV/EBITDA | 22.59 |
| Quarterly Earnings Growth (YoY) | 57.20% |
| Quarterly Revenue Growth (YoY) | 12.40% |
| Shares Outstanding | $157.16M |
| Float | $46.23M |
| % Insiders | 71.43% |
| % Institutions | 29.29% |
Analyst Ratings
Consensus ($46.40 target)
2
Strong Buy3
BuyData last updated: 4/9/2026